DGAP-News
IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies
DGAP-News: IMD Natural Solutions GmbH / Key word(s): Investment
IMD Natural Solutions Receives EUR4 Million Equity Investment from
Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural
Preservatives Technologies
31.08.2015 / 10:00
---------------------------------------------------------------------
Press Release
IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang
Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives
Technologies
Dortmund, Germany, and Taizhou City, China, August 31, 2015 - IMD Natural
Solutions GmbH (INS), a natural product company, today announced a
collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun;
SHA:600267) under which INS receives a EUR4 million equity investment and
provides Hisun access to INS' unique natural product lead discovery
platform for antimicrobials and antioxidants for the food, beverage and
personal care industries. Furthermore, INS will benefit from Hisun's
production know-how and capabilities.
The investment paves the way for INS to further develop and commercialize
its innovative antimicrobial preservation product for use in food, beverage
and personal care applications. It is a new, fermentation-based all-natural
agent with superior efficacy against yeasts, molds and other microbial
strains and has shown bioactivity against microbial organisms that have
adapted to current preservative agents. The collaboration provides Hisun
access to INS' natural product databases and technology for the
identification and development of suitable active natural ingredients for
various life science applications.
"The investment by Hisun into INS and our access to Hisun's production
know-how and capabilities are an important step in driving our core product
towards market entry," said Dr. Thomas Henkel, Managing Director of INS.
"The combination of INS's natural product platform and product candidates
with Hisun's production know-how creates a unique platform for the
development and commercialization of new, innovative products and thus
strengthens our market position and pipeline potential substantially," said
Mr. Bai Hua, President and CEO of Hisun.
About IMD Natural Solutions GmbH
IMD Natural Solutions GmbH (INS) was founded in 2012 in Dortmund, Germany.
The management has more than 20 years of experience in the discovery and
development of active compounds derived from natural products. INS owns
extensive proprietary natural product and genetic source collections, a
unique technology platform as well as broad chemical and biological
databases. INS develops and commercializes innovative ingredients - with a
special focus on preservative agents - derived from totally natural
sources. The main target markets are in the food, beverages and personal
care industries.
About Zhejiang Hisun Pharmaceuticals
Founded in 1956, the vision of Zhejiang Hisun Pharmaceuticals Co., Ltd.
(stock code 600267) is to become "a widely respected international
pharmaceutical company" by advancing its mission of "persisting in
pharmaceutical innovation for the benefit of human beings." The Company
focuses on the integration of pharmaceutical research and development (R&D)
with production resources in order to provide its global customers with
outstanding products and services. To date, over 40 of the Company's
products have passed certification by the FDA (U.S.), EDQM (EU), TGA
(Australia), KFDA (Korea), etc., and are sold in more than 30 countries
worldwide. To learn more about Hisun, please visit
http://www.hisunpharm.com/.
Contact
Dr. Thomas Henkel, Managing Director
IMD Natural Solutions GmbH
Phone: +49-231-9742-7400
Email: thomas.henkel@imd-natural-solutions.com
Internet: www.imd-natural-solutions.com
Wei Zhang, Secretary of board
Zhejiang HISUN Pharmaceutical Co., Ltd.
Phone: +86-0576-88827809
Email: stock600267@hisunpharm.com
Internet: www.hisunpharm.com
Raimund Gabriel, Managing Partner
MC Services AG
Phone: +49-89-210228-30
Email: raimund.gabriel@mc-services.eu
Internet: www.mc-services.eu
---------------------------------------------------------------------
31.08.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
390439 31.08.2015
Press Release
IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang
Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives
Technologies
Dortmund, Germany, and Taizhou City, China, August 31, 2015 - IMD Natural
Solutions GmbH (INS), a natural product company, today announced a
collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun;
SHA:600267) under which INS receives a EUR4 million equity investment and
provides Hisun access to INS' unique natural product lead discovery
platform for antimicrobials and antioxidants for the food, beverage and
personal care industries. Furthermore, INS will benefit from Hisun's
production know-how and capabilities.
The investment paves the way for INS to further develop and commercialize
its innovative antimicrobial preservation product for use in food, beverage
and personal care applications. It is a new, fermentation-based all-natural
agent with superior efficacy against yeasts, molds and other microbial
strains and has shown bioactivity against microbial organisms that have
adapted to current preservative agents. The collaboration provides Hisun
access to INS' natural product databases and technology for the
identification and development of suitable active natural ingredients for
various life science applications.
"The investment by Hisun into INS and our access to Hisun's production
know-how and capabilities are an important step in driving our core product
towards market entry," said Dr. Thomas Henkel, Managing Director of INS.
"The combination of INS's natural product platform and product candidates
with Hisun's production know-how creates a unique platform for the
development and commercialization of new, innovative products and thus
strengthens our market position and pipeline potential substantially," said
Mr. Bai Hua, President and CEO of Hisun.
About IMD Natural Solutions GmbH
IMD Natural Solutions GmbH (INS) was founded in 2012 in Dortmund, Germany.
The management has more than 20 years of experience in the discovery and
development of active compounds derived from natural products. INS owns
extensive proprietary natural product and genetic source collections, a
unique technology platform as well as broad chemical and biological
databases. INS develops and commercializes innovative ingredients - with a
special focus on preservative agents - derived from totally natural
sources. The main target markets are in the food, beverages and personal
care industries.
About Zhejiang Hisun Pharmaceuticals
Founded in 1956, the vision of Zhejiang Hisun Pharmaceuticals Co., Ltd.
(stock code 600267) is to become "a widely respected international
pharmaceutical company" by advancing its mission of "persisting in
pharmaceutical innovation for the benefit of human beings." The Company
focuses on the integration of pharmaceutical research and development (R&D)
with production resources in order to provide its global customers with
outstanding products and services. To date, over 40 of the Company's
products have passed certification by the FDA (U.S.), EDQM (EU), TGA
(Australia), KFDA (Korea), etc., and are sold in more than 30 countries
worldwide. To learn more about Hisun, please visit
http://www.hisunpharm.com/.
Contact
Dr. Thomas Henkel, Managing Director
IMD Natural Solutions GmbH
Phone: +49-231-9742-7400
Email: thomas.henkel@imd-natural-solutions.com
Internet: www.imd-natural-solutions.com
Wei Zhang, Secretary of board
Zhejiang HISUN Pharmaceutical Co., Ltd.
Phone: +86-0576-88827809
Email: stock600267@hisunpharm.com
Internet: www.hisunpharm.com
Raimund Gabriel, Managing Partner
MC Services AG
Phone: +49-89-210228-30
Email: raimund.gabriel@mc-services.eu
Internet: www.mc-services.eu
---------------------------------------------------------------------
31.08.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
390439 31.08.2015